Decrease in the AgNOR number in Dunning R3327 prostate cancers after treatment with an agonist and antagonist of luteinizing hormone-releasing hormone.
about
Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes.Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers.Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215.
P2860
Decrease in the AgNOR number in Dunning R3327 prostate cancers after treatment with an agonist and antagonist of luteinizing hormone-releasing hormone.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Decrease in the AgNOR number i ...... ing hormone-releasing hormone.
@ast
Decrease in the AgNOR number i ...... ing hormone-releasing hormone.
@en
type
label
Decrease in the AgNOR number i ...... ing hormone-releasing hormone.
@ast
Decrease in the AgNOR number i ...... ing hormone-releasing hormone.
@en
prefLabel
Decrease in the AgNOR number i ...... ing hormone-releasing hormone.
@ast
Decrease in the AgNOR number i ...... ing hormone-releasing hormone.
@en
P2093
P2860
P1476
Decrease in the AgNOR number i ...... ing hormone-releasing hormone.
@en
P2093
A V Schally
K Szepeshazi
P2860
P304
P407
P577
1991-05-01T00:00:00Z